Yoshiaki Katsuda

981 total citations
22 papers, 546 citations indexed

About

Yoshiaki Katsuda is a scholar working on Physiology, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Yoshiaki Katsuda has authored 22 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Yoshiaki Katsuda's work include Regulation of Appetite and Obesity (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Diet and metabolism studies (4 papers). Yoshiaki Katsuda is often cited by papers focused on Regulation of Appetite and Obesity (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Diet and metabolism studies (4 papers). Yoshiaki Katsuda collaborates with scholars based in Japan, United States and United Kingdom. Yoshiaki Katsuda's co-authors include Masami Shinohara, Taku Masuyama, Takeshi Ohta, Tomohiko Sasase, Katsuhiro Miyajima, Takahisa Yamada, Kajuro Komeda, Toshiyuki Shoda, Akihiro Kakehashi and Bin Tong and has published in prestigious journals such as Scientific Reports, Biological Psychiatry and Bioscience Biotechnology and Biochemistry.

In The Last Decade

Yoshiaki Katsuda

20 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiaki Katsuda Japan 12 155 149 130 110 61 22 546
Vivian C. Calegari Brazil 10 150 1.0× 125 0.8× 82 0.6× 72 0.7× 74 1.2× 14 428
Nanae Nagata Japan 16 238 1.5× 103 0.7× 44 0.3× 108 1.0× 34 0.6× 48 739
Sébastien Foulquier Netherlands 15 348 2.2× 71 0.5× 98 0.8× 52 0.5× 16 0.3× 35 818
Judith A. Herlein United States 12 248 1.6× 156 1.0× 49 0.4× 75 0.7× 29 0.5× 13 584
Yasir Abdul United States 16 308 2.0× 111 0.7× 67 0.5× 39 0.4× 29 0.5× 43 832
Mary K. McGahon United Kingdom 19 481 3.1× 309 2.1× 58 0.4× 67 0.6× 43 0.7× 35 1.0k
Taku Masuyama Japan 13 268 1.7× 241 1.6× 235 1.8× 227 2.1× 112 1.8× 27 752
Bryan Bollman United States 8 239 1.5× 312 2.1× 36 0.3× 23 0.2× 57 0.9× 11 984
Meng Hu China 14 238 1.5× 116 0.8× 28 0.2× 46 0.4× 29 0.5× 22 622
Masahiko Terada Japan 14 138 0.9× 378 2.5× 57 0.4× 43 0.4× 24 0.4× 29 730

Countries citing papers authored by Yoshiaki Katsuda

Since Specialization
Citations

This map shows the geographic impact of Yoshiaki Katsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Katsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Katsuda more than expected).

Fields of papers citing papers by Yoshiaki Katsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Katsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Katsuda. The network helps show where Yoshiaki Katsuda may publish in the future.

Co-authorship network of co-authors of Yoshiaki Katsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Katsuda. A scholar is included among the top collaborators of Yoshiaki Katsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Katsuda. Yoshiaki Katsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Kazuma, Yukari Kimoto, Yoshihisa Okamoto, et al.. (2025). Pharmacological Inhibition of ROR<i>γ</i> Ameliorates Skin Inflammation Induced by Both Antigen- and Cytokine-Activated Th17 Cells. PubMed. 48(7). 1040–1048.
2.
Kobayashi, Kazuma, Hidenori Iwasaki, Yoshihisa Okamoto, et al.. (2025). Suppressive Effects of JTE-151, a Novel Orally Available ROR<i>γ</i> Antagonist, in Experimental Models of Rheumatoid Arthritis. Biological and Pharmaceutical Bulletin. 48(7). 1118–1124.
3.
4.
Tao, Hai‐Yan, Scott M. Thacher, Kazuma Kobayashi, et al.. (2024). Pharmacological Properties of JTE-151; A Novel Orally Available RORγ Antagonist That Suppresses Th17 Cell-Related Responses <i>in Vitro</i> and <i>in Vivo</i>. Biological and Pharmaceutical Bulletin. 47(12). 2050–2057. 3 indexed citations
5.
Katsuda, Yoshiaki, et al.. (2024). Pharmacological Properties of Tapinarof in Mice as a Novel Topical Agent for Plaque Psoriasis. 7(4). 116–122. 1 indexed citations
6.
Sasase, Tomohiko, Yukihito Ishii, Yoshiaki Katsuda, et al.. (2020). The sphingosine‐1‐phosphate receptor modulator, FTY720, prevents the incidence of diabetes in Spontaneously Diabetic Torii rats. Clinical and Experimental Pharmacology and Physiology. 48(6). 869–876. 7 indexed citations
7.
8.
Noguchi, Masato, Akihiro Nomura, Satoki Doi, et al.. (2018). Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction. Scientific Reports. 8(1). 17374–17374. 14 indexed citations
9.
Tanimoto, Atsuo, Yuichi Shinozaki, Yasuo Yamamoto, et al.. (2017). A novelJAKinhibitorJTE‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents. Experimental Dermatology. 27(1). 22–29. 50 indexed citations
10.
Katsuda, Yoshiaki, et al.. (2015). Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin. EXPERIMENTAL ANIMALS. 64(2). 161–169. 37 indexed citations
11.
Ohta, Takeshi, Yoshiaki Katsuda, Katsuhiro Miyajima, et al.. (2014). Gender Differences in Metabolic Disorders and Related Diseases in Spontaneously Diabetic Torii-LeprfaRats. Journal of Diabetes Research. 2014. 1–7. 32 indexed citations
12.
Katsuda, Yoshiaki, et al.. (2014). Effects of Unilateral Nephrectomy on Renal Function in Male Spontaneously Diabetic Torii Fatty Rats: A Novel Obese Type 2 Diabetic Model. Journal of Diabetes Research. 2014. 1–6. 12 indexed citations
13.
Katsuda, Yoshiaki, et al.. (2014). Effects of salt intake on blood pressure and renal function in Spontaneously Diabetic Torii (SDT) fatty rat. 9–14. 1 indexed citations
14.
Katsuda, Yoshiaki, et al.. (2014). Physiological changes induced by salt intake in female Spontaneously Diabetic Torii‐Leprfa (SDT fatty) rat, a novel obese type 2 diabetic model. Animal Science Journal. 85(5). 588–594. 7 indexed citations
15.
Katsuda, Yoshiaki, Takeshi Ohta, Katsuhiro Miyajima, et al.. (2014). Diabetic Complications in Obese Type 2 Diabetic Rat Models. EXPERIMENTAL ANIMALS. 63(2). 121–132. 73 indexed citations
16.
Katsuda, Yoshiaki, Takeshi Ohta, Masami Shinohara, Bin Tong, & Takahisa Yamada. (2013). Diabetic mouse models. Open Journal of Animal Sciences. 3(4). 334–342. 16 indexed citations
17.
Masuyama, Taku, Yoshiaki Katsuda, & Masami Shinohara. (2005). A Novel Model of Obesity-Related Diabetes: Introgression of the Leprfa Allele of the Zucker Fatty Rat into Nonobese Spontaneously Diabetic Torii (SDT) Rats. EXPERIMENTAL ANIMALS. 54(1). 13–20. 64 indexed citations
18.
Shinohara, Masami, Taku Masuyama, Toshiyuki Shoda, et al.. (1999). A New Spontaneously Diabetic Non‐obese Torii Rat Strain With Severe Ocular Complications. Journal of Diabetes Research. 1(2). 89–100. 149 indexed citations
19.
Saito, Shinji, Yoshiaki Katsuda, Osamu Johdo, & Akihiro Yoshimoto. (1995). New Rhodomycin Analogs, SS-288A and SS-288B, Produced by aStreptomyces violaceusA262 Mutant. Bioscience Biotechnology and Biochemistry. 59(1). 135–137. 4 indexed citations
20.
Katsuda, Yoshiaki, Anne E.S. Walsh, Chris Ware, Philip J. Cowen, & Ann L. Sharpley. (1993). meta-Chlorophenylpiperazine decreases slow-wave sleep in humans. Biological Psychiatry. 33(1). 49–51. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivian C. Calegari Breakdown of academic impact, for papers by Nanae Nagata Breakdown of academic impact, for papers by Sébastien Foulquier Breakdown of academic impact, for papers by Judith A. Herlein Breakdown of academic impact, for papers by Yasir Abdul Breakdown of academic impact, for papers by Mary K. McGahon Breakdown of academic impact, for papers by Taku Masuyama Breakdown of academic impact, for papers by Bryan Bollman Breakdown of academic impact, for papers by Meng Hu Breakdown of academic impact, for papers by Masahiko Terada
Rankless by CCL
2026